Seres Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	45.77	30.79	127.97	163.03	180
Short-Term Investments	-	-	-	18.31	110.7
Cash & Short-Term Investments	45.77	30.79	127.97	181.34	290.71
Cash Growth	48.63%	-75.94%	-29.43%	-37.62%	14.62%
Accounts Receivable	0.16	-	-	-	-
Other Receivables	0.36	2.07	-	-	-
Total Trade Receivables	0.52	2.07	-	-	-
Other Current Assets	3.09	5.81	47.45	13.42	12.92
Total Current Assets	49.38	38.67	175.41	194.76	303.63
Net Property, Plant & Equipment	80.12	92.44	108.03	133.97	36.15
Long-Term Investments	-	-	-	-	0.5
Other Long-Term Assets	8.7	8.7	75.16	20.05	14.59
Total Assets	138.19	139.81	358.6	348.78	354.86
Accounts Payable	1.68	4.08	3.64	17.44	13.74
Accrued Expenses	7.25	28.47	22.51	59.84	45.09
Current Portion of Long-Term Debt	-	-	-	0.46	-
Current Portion of Leases	10.39	8.67	5.59	3.6	6.61
Unearned Revenue	-	-	-	4.26	16.82
Other Current Liabilities	-	-	66.92	-	-
Total Current Liabilities	19.32	41.22	98.66	85.6	82.26
Long-Term Debt	-	-	101.54	50.59	24.64
Long-Term Leases	72.58	82.97	91.65	107.94	17.96
Other Long-Term Liabilities	2.08	1.84	111.6	93.87	98.49
Total Long-Term Liabilities	74.65	84.8	304.8	252.41	141.09
Total Liabilities	93.98	126.03	403.46	338	223.35
Common Stock	0.01	0.01	0.14	0.13	0.09
Additional Paid-in Capital	1,017	991.87	933.24	875.18	745.83
Accumulated Other Comprehensive Income	-	-	-	-0.01	-0.06
Retained Earnings	-972.4	-978.1	-978.24	-864.51	-614.35
Shareholders' Equity	44.22	13.78	-44.86	10.78	131.51
Total Liabilities & Equity	138.19	139.81	358.6	348.78	354.86
Total Debt	82.97	91.64	198.78	162.59	49.21
Net Cash (Debt)	-37.2	-60.85	-70.82	18.75	241.5
Net Cash Growth	-	-	-	-92.23%	13.46%
Net Cash Per Share	-4.19	-7.83	-11.06	3.47	52.67
Book Value	44.22	13.78	-44.86	10.78	131.51
Book Value Per Share	4.99	1.77	-7.01	2.00	28.68
Tangible Book Value	44.22	13.78	-44.86	10.78	131.51
Tangible Book Value Per Share	4.99	1.77	-7.01	2.00	28.68

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q